chr17-48597819-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_018952.5(HOXB6):​c.332A>G​(p.Asp111Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,455,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

HOXB6
NM_018952.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.689

Publications

0 publications found
Variant links:
Genes affected
HOXB6 (HGNC:5117): (homeobox B6) This gene is a member of the Antp homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development, including that of lung and skin, and has been localized to both the nucleus and cytoplasm. Altered expression of this gene or a change in the subcellular localization of its protein is associated with some cases of acute myeloid leukemia and colorectal cancer. [provided by RefSeq, Jul 2008]
HOXB-AS3 (HGNC:40283): (HOXB cluster antisense RNA 3)
HOXB3 (HGNC:5114): (homeobox B3) This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Increased expression of this gene is associated with a distinct biologic subset of acute myeloid leukemia (AML). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07597658).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HOXB6NM_018952.5 linkc.332A>G p.Asp111Gly missense_variant Exon 3 of 4 ENST00000225648.4 NP_061825.2 P17509-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HOXB6ENST00000225648.4 linkc.332A>G p.Asp111Gly missense_variant Exon 3 of 4 1 NM_018952.5 ENSP00000225648.3 P17509-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1455366
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
723306
show subpopulations
African (AFR)
AF:
0.0000300
AC:
1
AN:
33304
American (AMR)
AF:
0.00
AC:
0
AN:
44224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25966
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39402
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52696
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
9.02e-7
AC:
1
AN:
1108794
Other (OTH)
AF:
0.00
AC:
0
AN:
60060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000312
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 12, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.332A>G (p.D111G) alteration is located in exon 3 (coding exon 1) of the HOXB6 gene. This alteration results from a A to G substitution at nucleotide position 332, causing the aspartic acid (D) at amino acid position 111 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Uncertain
0.031
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
21
DANN
Benign
0.87
DEOGEN2
Benign
0.13
T;T
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.78
.;T
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.076
T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
-0.81
N;N
PhyloP100
0.69
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.030
N;N
REVEL
Benign
0.28
Sift
Benign
0.52
T;T
Sift4G
Benign
0.52
T;T
Polyphen
0.0030
B;B
Vest4
0.16
MutPred
0.17
Loss of stability (P = 0.0989);Loss of stability (P = 0.0989);
MVP
0.90
MPC
0.44
ClinPred
0.23
T
GERP RS
5.4
Varity_R
0.11
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070348832; hg19: chr17-46675181; API